Search

Author/Creator Nabors, L Burt

2. ACTR-14. PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM. (5th November 2018)

Authors:
Alexander, Brian; Supko, Jeffrey; Agar, Nathalie; Ahluwalia, Manmeet; Desai, Arati; Dietrich, Jorg; Kaley, Thomas; Peereboom, David; Takebe, Naoko; Desideri, Serena; Fisher, Joy; Sims, Megan; Ye, Xiaobu; Ligon, Keith; Nabors, L Burt; Grossman, Stuart; Wen, Patrick
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. ACTR-20. A SMALL MOLECULE AXL INHIBITOR, BGB324 – FIRST-IN-HUMAN GBM SURGICAL PK TRIAL FOR RECURRENT TUMORS. (5th November 2018)

Authors:
Ghosh, Sadashib; Sadahiro, Hirokazu; Kang, Kyung-Don; Gibson, Justin T; Minata, Mutsuko; Yu, Hai; Shi, Junfeng; Chhipa, Rishi; Chen, Zhihong; Lu, Songjian; Simoni, Yannick; Furuta, Takuya; Sabit, Hemragul; Zhang, Suojun; Bastola, Soniya; Yamaguchi, Shinobu; Alsheikh, Heba Allah; Komarova, Svetlan...
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery. Issue 10 (7th June 2020)

Authors:
Grossman, Stuart A; Romo, Carlos G; Rudek, Michelle A; Supko, Jeffrey; Fisher, Joy; Nabors, L Burt; Wen, Patrick Y; Peereboom, David M; Ellingson, Benjamin M; Elmquist, William; Barker, Fred G; Kamson, David; Sarkaria, Jann N; Timmer, William; Bindra, Ranjit S; Ye, Xiaobu
Journal:
Neuro-oncology
Issue:
Volume 22:Issue 10(2020)
Page Start:
1422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. CTIM-11. PHASE 2 STUDY OF SL-701, A NOVEL IMMUNOTHERAPY, IN ADULTS WITH RECURRENT GBM: A HIGH PARAMETER FLOW CYTOMETRY ANALYSIS OF CD8+ T CELLS AND POTENTIAL IMPLICATIONS FOR PATIENT ENRICHMENT STRATEGIES. (12th November 2021)

Authors:
Peereboom, David; Lindsay, Ross; Badruddoja, Michael; Nabors, L Burt; Kumthekar, Priya; Lieberman, Frank; Tran, David; Phuphanich, Surasak; Schiff, David; Sherman, Jonathan; Butowski, Nicholas; Dunbar, Erin; Fink, Karen; Iwamoto, Fabio; Moertel, Christopher; Schulder, Michael; Walbert, Tobias; Ha...
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. CTIM-13. PHASE 1 CLINICAL TRIAL OF ONCOLYTIC VIRAL IMMUNOTHERAPY WITH CAN-2409 + VALACYCLOVIR IN COMBINATION WITH NIVOLUMAB AND STANDARD OF CARE (SOC) IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA (HGG). (12th November 2021)

Authors:
Wen, Patrick; Aguilar, Laura; Ye, Xiaobu; Reardon, David; Bi, Wenya Linda; Peruzzi, Pierpaolo; Patel, Nirav; Strowd, Roy; Tatter, Stephen; Lee, Ian; Walbert, Tobias; Snyder, James; Brem, Steven; Desai, Arati; Bagley, Stephen; Amankulor, Nduka; Lieberman, Frank; Mantica, Megan; Lopez, Lenika; Bell...
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GBM: IDENTIFICATION OF TREATMENT-INDUCED CD8+CD107A+ CD57+ PD-1- MEMORY T-CELLS THAT ARE ASSOCIATED WITH INCREASED SURVIVAL. (14th November 2022)

Authors:
Peereboom, David; Lindsay, Ross; Badruddoja, Michael; Nabors, L Burt; Kumthekar, Priya; Lieberman, Frank; Tran, David; Phuphanich, Surasak; Schiff, David; Sherman, Jonathan; Butowski, Nicholas; Dunbar, Erin; Fink, Karen; Iwamoto, Fabio; Moertel, Christopher; Schulder, Michael; Walbert, Tobias; Ha...
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. CTNI-05. PRELIMINARY RESULTS OF THE NERATINIB ARM IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II PLATFORM TRIAL USING BAYESIAN ADAPTIVE RANDOMIZATION. (12th November 2021)

Authors:
Arrillaga-Romany, Isabel; Trippa, Lorenzo; Fell, Geffrey; Lee, Eudocia Quant; Rahman, Rifaquat; Touat, Mehdi; McCluskey, Christine; Bruno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Hei...
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. CTNI-18. PHASE I AND PRELIMINARY PHASE 0 RESULTS OF ABTC 1801: A MULTI-ARM CLINICAL TRIAL OF THE PARP INHIBITOR PAMIPARIB (BGB290) WITH VERY LOW DOSE METRONOMIC TEMOZOLOMIDE IN RECURRENT IDH MUTANT GLIOMAS. (12th November 2021)

Authors:
Schiff, David; Bindra, Ranjit; Li, Jing; Ye, Xiaobu; Ellingson, Benjamin; Walbert, Tobias; Campian, Jian; Nabors, L Burt; Lieberman, Frank; Ozer, Byran; Desai, Arati; Omuro, Antonio; Wen, Patrick; Desideri, Serena; Fisher, Joy; Grossman, Stuart
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗